Q4 2023 · 13F-HR
Monashee Investment Management LLCholdings as filed
Filed 2024-02-12 · accession 0001172661-24-000711
$566.5M
Reported value
44
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 464287200 | IVV | ISHARES TR | $118.8M | 21.0% | 248,710 | Common | SOLE |
| 922908363 | VOO | VANGUARD INDEX FDS | $118.4M | 20.9% | 271,010 | Common | SOLE |
| 921943858 | VEA | VANGUARD TAX-MANAGED FDS | $74.2M | 13.1% | 1,549,700 | Common | SOLE |
| 46432F842 | IEFA | ISHARES TR | $55.0M | 9.72% | 782,380 | Common | SOLE |
| 922042858 | VWO | VANGUARD INTL EQUITY INDEX F | $38.8M | 6.84% | 942,960 | Common | SOLE |
| 46434G103 | IEMG | ISHARES INC | $33.4M | 5.90% | 660,700 | Common | SOLE |
| 464287150 | ITOT | ISHARES TR | $22.8M | 4.03% | 216,860 | Common | SOLE |
| 922908769 | VTI | VANGUARD INDEX FDS | $22.8M | 4.02% | 96,060 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $7.8M | 1.38% | 191,855 | Common | SOLE |
| N00985106 | AER | AERCAP HOLDINGS NV | $6.7M | 1.18% | 90,000 | Common | SOLE |
| 69331C108 | PCG | PG&E CORP | $4.7M | 0.83% | 260,000 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $4.4M | 0.77% | 90,805 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $4.0M | 0.71% | 175,000 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $4.0M | 0.70% | 100,209 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $3.9M | 0.69% | 350,000 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $3.8M | 0.67% | 10,000 | Common | SOLE |
| 517834107 | LVS | LAS VEGAS SANDS CORP | $3.7M | 0.65% | 75,000 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $3.2M | 0.56% | 3,459,854 | Common | SOLE |
| 641871108 | — | AMBRX BIOPHARMA INC | $3.0M | 0.52% | 207,500 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $2.9M | 0.52% | 70,000 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $2.7M | 0.48% | 73,949 | Common | SOLE |
| 71424F105 | PR | PERMIAN RESOURCES CORP | $2.4M | 0.42% | 175,900 | Common | SOLE |
| 34379V103 | FLNC | FLUENCE ENERGY INC | $2.4M | 0.42% | 100,000 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $2.4M | 0.42% | 37,500 | Common | SOLE |
| 92540K109 | VTMX | VESTA REAL ESTATE CORP | $2.2M | 0.38% | 55,000 | Common | SOLE |
| 02215L209 | KNTK | KINETIK HOLDINGS INC | $2.2M | 0.38% | 64,900 | Common | SOLE |
| 49845K101 | KVYO | KLAVIYO INC | $1.9M | 0.34% | 68,974 | Common | SOLE |
| 05153U107 | AURA | AURA BIOSCIENCES INC | $1.8M | 0.31% | 198,415 | Common | SOLE |
| 40416E103 | HCI | HCI GROUP INC | $1.7M | 0.31% | 19,790 | Common | SOLE |
| 21871X109 | CRBG | COREBRIDGE FINL INC | $1.6M | 0.29% | 75,000 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $1.6M | 0.28% | 140,000 | Common | SOLE |
| 78163D100 | RWAY | RUNWAY GROWTH FINANCE CORP | $1.2M | 0.20% | 91,739 | Common | SOLE |
| 02083G100 | NVLSEUR | ALPINE IMMUNE SCIENCES INC | $964,103 | 0.17% | 74,792 | Common | SOLE |
| 62855J104 | MYGN | MYRIAD GENETICS INC | $957,000 | 0.17% | 50,000 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $780,000 | 0.14% | 500,000 | Common | SOLE |
| 82024L103 | STTK | SHATTUCK LABS INC | $713,000 | 0.13% | 100,000 | Common | SOLE |
| 037326105 | ANTX | AN2 THERAPEUTICS INC | $696,599 | 0.12% | 33,997 | Common | SOLE |
| 09609G100 | — | BLUEBIRD BIO INC | $690,000 | 0.12% | 500,000 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $521,665 | 0.09% | 103,300 | Common | SOLE |
| 608550208 | MTEMEUR | MOLECULAR TEMPLATES INC | $454,467 | 0.08% | 121,841 | Common | SOLE |
| 171757107 | — | CIDARA THERAPEUTICS INC | $293,065 | 0.05% | 369,099 | Common | SOLE |
| 92854T100 | — | VIVID SEATS INC | $189,600 | 0.03% | 30,000 | Common | SOLE |
| 74623V103 | PCT | PURECYCLE TECHNOLOGIES INC | $47,604 | 0.01% | 11,754 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $34,923 | 0.01% | 132,435 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.